Advertising

Editorial
Volume 53, Issue 5, May 2024

Urology

David Homewood    Niall M Corcoran    Damien Bolton   
doi: 10.31128/AJGP-03-24-7192   |    Download article
Cite this article    BIBTEX    REFER    RIS

ArticleImage

Guest Editorial: Advances in urology

Innovation distinguishes between a leader and a follower.

­– Steve Jobs1

Good communication is the bridge between confusion and clarity.

– Nat Turner2

The volume of total medical knowledge is expanding at an exponential rate, with estimations of doubling in the 50 years prior to 1950, 7 years by 1980, 3.5 years by 2010 and just 0.2 years, or 73 days, by 2020.3 Rapid innovation benefits patient care by enabling novel solutions to previously untreatable pathology. However, effective subsequent practice change requires active formulation and dissemination of knowledge through various trusted information channels.4 In this Urological Society of Australia and New Zealand (USANZ) edition of the Australian Journal of General Practice, we explore contemporary challenges and breakthroughs in urology, aiming to provide practical insights for primary care physicians.

Prostate cancer remains a significant health concern in Australia. We discuss contemporary approaches to conservative management,5 and then trace the evolution of hormonal therapy, highlighting the role of androgen deprivation therapy (ADT) and emphasise the contemporary importance of added androgen receptor pathway inhibitors.6

Gender affirmation surgeries are set to play an increasing role in the management of gender dysphoria. We outline surgical options and referral criteria, advocating for a holistic multidisciplinary approach to ensure comprehensive care for transgender individuals.7

Recurrent urinary tract infections (rUTIs) often pose challenges in primary care.8,9 Through a narrative review, Wynn et al simplify rUTIs with a stepwise approach to diagnosis and management with further exploration of contemporary strategies and emerging therapies.10

Managing obstructive lower urinary tract symptoms (LUTS) in the medically comorbid patient has historically been difficult. Yanada et al explore innovations in minimally invasive surgical interventions, elucidating how an expanding urological toolkit is enabling tailored surgical approaches to individual patient needs.11

Finally, McDonald et al delve into advances in the management of urinary incontinence in the post mesh era with a stepwise, pragmatic approach.12

Although urologists have shown innovation across instrument design, robotics and surgical techniques well beyond the scope of this issue, we hope the chosen topics provide a set of practical reference points for the busy general practitioner.

This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Woo B. Steve Jobs quote. Forbes, 2013. Available at www.forbes.com/sites/bwoo/2013/02/14/innovation-distinguishes-between-a-leader-and-a-follower/?sh=75611c342844 [Accessed 2 March 2024]. Search PubMed
  2. Tang L. Nat Turner quote. Lehigh University, 2021. Available at https://wordpress.lehigh.edu/rcbc-blog/2021/03/10/good-communication-is-the-bridge-between-confusion-and-clarity-nat-turner/ [Accessed 2 March 2024]. Search PubMed
  3. Densen P. Challenges and opportunities facing medical education. Trans Am Clin Climatol Assoc 2011;122:48–58. Search PubMed
  4. Brownson RC, Eyler AA, Harris JK, Moore JB, Tabak RG. Getting the word out: New approaches for disseminating public health science. J Public Health Manag Pract 2018;24(2):102–11. doi: 10.1097/PHH.0000000000000673. Search PubMed
  5. Homewood D, Lucas H, Kennedy C, Majer J, Sathianathen N, Corcoran NM. When less is more: Updates in active surveillance and watchful waiting in the management of prostate cancer. Aust J Gen Pract 2024;53(5):253–57. Search PubMed
  6. Homewood D, Fu MH, Sathianathen N, La Bianca S, Tran B, Cocoran NM. Evolution of hormonal therapy for prostate cancer. Aust J Gen Pract 2024;53(5):291–300. Search PubMed
  7. Homewood D, Kennedy C, Goossen H, Blecher G. Urological focus on gender affirmation surgery. Aust J Gen Pract 2024;53(5):275–82. Search PubMed
  8. Flower A, Winters D, Bishop FL, Lewith G. The challenges of treating women with recurrent urinary tract infections in primary care: A qualitative study of GPs’ experiences of conventional management and their attitudes towards possible herbal options. Prim Health Care Res Dev 2015;16(6):597–606. doi: 10.1017/S1463423615000201. Search PubMed
  9. McKertich K, Hanegbi U. Recurrent UTIs and cystitis symptoms in women. Aust J Gen Pract 2021;50(4):199–205. doi: 10.31128/AJGP-11-20-5728. Search PubMed
  10. Wynn J, Homewood D, Tse V, et al. What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Aust J Gen Pract 2024;53(5):265–73. Search PubMed
  11. Yanada BA, Homewood D, Reeves F, Bolton D. Minimally invasive interventions for lower urinary tract symptoms: What sits between medical therapy and transurethral resection of the prostate. Aust J Gen Pract 2024;53(5):258–63. Search PubMed
  12. McDonald J, Homewood D, West C, Fong E, Elmer S. Managing female stress urinary incontinence in a post mesh era: What to do and when to refer. Aust J Gen Pract 2024;53(5):283–88. Search PubMed

EditorialUrology

Download article